Dr RR Baliga's "Got Knowledge Doc" Podkast

🫀🧬 Cardio-Oncology: where modern cancer cures meet the heart   As cancer survival improves, cardiovascular toxicity has emerged as a defining challenge of our time. From BTK inhibitor–associated atrial fibrillation ⚡ , to immune checkpoint inhibitor myocarditis 🔥 , to VEGF-driven hypertension 🩸 , the heart increasingly pays the price of precision oncology.   This FAQ-driven, clinician-ready C...

🧬 Prediabetes remission is not just metabolic—it's cardiovascular medicine. ❤️ A new analysis in The Lancet Diabetes & Endocrinology shows that achieving remission to normoglycaemia —not merely delaying diabetes—was associated with a ~50% reduction in cardiovascular death or heart failure hospitalisation , with benefits persisting for 20–30 years across U.S. and Chinese cohorts ⏳📉.   🔍 The mes...

🔬 New Insights on MASLD from JAMA 🍃   I recently reviewed an excellent JAMA article on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) —now recognized as the most common chronic liver disease worldwide . The review highlights how metabolic dysfunction, inflammation, and fibrosis converge to drive long-term risks, including cardiovascular disease, hepatocellular carcinoma, and ex...

In this week's exploration, I dive into the brain's hidden "plumbing"—the glymphatic and meningeal lymphatic systems—drawing from a remarkable report in Science magazine (Dec 2025). The piece outlines emerging Alzheimer's strategies ranging from VEGF-C and Aquaporin-4 gene therapy to vasomotion drugs, CO₂ breathing, massage-based lymphatic stimulation, and even experimental lymphovenous surgery. A...

🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘   The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide , this chronic, relapsing disease demands integrated, equitable, lifelong care .   The guidance underscores two essen...

Delving into the latest JAHA review on immune checkpoint inhibitors and the heart has been illuminating 🔍❤️. As immunotherapy transforms cancer care, we're learning that unleashed T-cells can also stir the silent storms within vulnerable plaques ⚡🩺.   This piece beautifully unpacks how ICIs may accelerate atherosclerosis, heighten ACS risk, and challenge our diagnostic instincts—especially when...

Immanuel Kant: The Architect of Modern Reason 🧠✨   Fascinating to revisit Kant's legacy — the thinker who reshaped how we understand knowledge, morality, and human freedom. His ideas on autonomy , duty , and the categorical imperative continue to guide ethical reasoning in science, leadership, and society.   From Critique of Pure Reason to Perpetual Peace , Kant invites us to think boldly: What...

🚀 Immune checkpoint inhibitors have transformed cancer care—but they come with a cardiovascular shadow. A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. 🫀💡   Key insights include: • Early recognition with troponin, ECG, and CMR 🧪📊 • Smoldering vs...

  Chronic kidney disease now affects nearly 850 million people worldwide , yet early detection and simple, evidence-based interventions can dramatically change the trajectory of both kidney and cardiovascular health. 🌍🩺 The latest Lancet Seminar highlights powerful tools— eGFR + albuminuria staging, SGLT2 inhibitors, RAS blockade, statins, and GLP-1 therapies —that allow every clinician to make...

🚀 New insights from Cell shine a light on an unexpected ally in the fight against cognitive decline. A natural experiment from Wales shows that the shingles (herpes zoster) vaccine doesn't just prevent viral reactivation—it may also reduce new mild cognitive impairment and lower dementia-related mortality over long-term follow-up. 🔍 Using a strict birthday-based eligibility cutoff, the study pro...

📘 New NEJM Evidence for the 2025–26 Vaccine Season is out—and it delivers clarity at a time we need it most. The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19 , RSV , and Influenza , with reassuring safety profiles across age groups. 💉🛡️   Key insights: improved VE for updated Covid-19 strains, high efficacy of maternal RSV vaccination...

New Lancet Seminar on heart failure with reduced ejection fraction.  💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. It's a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice. Tune in to explore the science, the strategy, and...

🔍💓 Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts   Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it.   From CT angiography that unmasks non-obstructive plaque 🖥️➡️🫀 to stress PET/CMR that maps true ischemia under load 💨📊, multimodality imaging...

Exploring David Hume 🧠✨ Just revisited David Hume's extraordinary contributions to modern thought — a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, economics, and evidence-based decision-making. 🌍📚 H...

The U.S. heart failure landscape is transforming—and fast. 🫀📊   A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. 📉⚖️   These trends demand a new generation of HF trials —more inclusive, prevention-f...

🧬⏳ New Insights into Organ-Specific Aging! 🧠❤️🩺   Just explored a remarkable Nature Aging study showing how organ-specific proteomic clocks can forecast disease, cognitive decline, and even longevity with impressive precision. These clocks—built from >2,900 plasma proteins—reveal that the brain, kidney, and arteries age on their own timelines , each carrying unique clues about future health.  ...

Respiratory vaccines are not just infection-fighters—they're cardiovascular protectors. 💉🫀 The 2025 JACC Consensus reminds us that influenza, pneumococcal, COVID-19, RSV, and zoster vaccines reduce MI, HF decompensation, hospitalizations, and death in our most vulnerable patients.   As clinicians, we hold the power to translate evidence into prevention: strong recommendations, simple pathways, a...

The latest JAMA article on keratinocyte carcinomas 🌞—a timely reminder that BCC and cSCC remain the world's most common cancers, with more than 5.4 million cases annually in the US alone . The review highlights essential updates in epidemiology, high-risk features, prevention, and evidence-based management, especially the role of sun protection, actinic keratosis treatment, and risk-stratified su...

🚨 Food Anaphylaxis: New Mechanisms Unveiled 🍽️🧬   A superb NEJM review highlights how cysteinyl leukotrienes act as gatekeepers in the gut—opening antigen passages, expanding mast cells, and amplifying the risk of oral anaphylaxis . The work elegantly bridges basic lipid biology with real-world food allergy challenges, and points toward new preventive strategies beyond current IgE-based therapie...

🌿 What does the evidence really say about medical cannabis? A new JAMA review highlights a clear message: cannabis helps few conditions—and harms may outweigh benefits for many. 📉 Small benefit for nausea ⚡ Moderate benefit for select pediatric seizures 💊 Limited evidence for pain, insomnia, or psychiatric use ❤️ Risks rise with high-potency products, especially for heart and mental health.  ...

Thrilled to see a major step forward in dengue prevention! 🦟💊 A new NEJM study reports that daily mosnodenvir , a first-in-class antiviral targeting the NS3–NS4B interaction , significantly reduced DENV-3 viral load and prevented infection in a controlled human challenge model. 📉🧬 It's early, but the results offer real hope for a long-awaited oral dengue prophylaxis —with encouraging safety, s...

  Delighted to share a concise update on the latest NEJM review of Long QT Syndrome 🫀📘 — a masterful synthesis by Schwartz & Crotti that reframes how we recognize risk, personalize therapy, and prevent sudden death in this genetically mediated disorder. The piece highlights ion-channel biology , gene-specific triggers , the impact of modifier genes , and the effectiveness of a tiered therapeutic...

🧠✨ Leibniz: Harmony, Logic, and the Birth of the Digital Mind   Celebrating Gottfried Wilhelm Leibniz — the mathematician-philosopher who co-created calculus , invented binary arithmetic , and envisioned a world stitched together by pre-established harmony . His Monadology reads like proto-systems theory, and his binary system is the quiet ancestor of every computer we use today.   For clinician...

🧬  New insights into autism : A 2025 JCI Viewpoint highlights how hundreds of genes , polygenic risk , and specific environmental factors converge during fetal brain development to shape autism likelihood. 🧠 Early biomarkers—from infant MRI and ERPs to machine-learning models using EHR data—are accelerating earlier, more tailored interventions. 🌱 Advances in gene therapy, IGF-1 pathways, and pr...

🔍 Peripheral Neuropathy: What Clinicians Should Know 🧠⚡   Peripheral neuropathy affects ~1% of adults worldwide, with diabetes accounting for more than half of all cases. The JAMA review highlights why length-dependent patterns dominate, how metabolic stress injures long axons first, and why sensory symptoms outpace motor loss. Evidence-based evaluation still begins with glucose testing, vitami...